C16H15F2N3NaO4S
406.4 g/mol
APIWarning
Sodium 5-Difluoromethoxy-2(((3,4-dimethoxy-2-Pyridinyl)-methyl)-sulfinyl)-1H benzimidazole
CAS138786-67-1EC604-093-4
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
This compound is a sodium salt form of a difluoromethoxy-substituted heterocyclic sulfoxide. It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing.
active pharmaceutical ingredientpharmaceutical raw material
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138786-67-1
Related Compounds
StrongSame Parent
Pantoprazole sodium hydrate
CAS164579-32-2
pharmaceutical raw material
ReferenceSame Category
Ibandronate sodium
CAS138844-81-2
pharmaceutical raw material
ReferenceSame Category
Brinzolamide
CAS138890-62-7
pharmaceutical raw material
ReferenceSame Category
(2S,3S,4S,5R,6S)-6-[3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
CAS138921-77-4
pharmaceutical raw material
ReferenceSame Category
Ibandronate sodium hydrate
CAS138926-19-9
pharmaceutical raw material
Referencesame scaffold
(R)-Omeprazole sodium
CAS161796-77-6
pharmaceutical raw material
Referencesame scaffold
(R)-Rabeprazole sodium
CAS171440-18-9
pharmaceutical raw material
Referencesame scaffold
Rabeprazole sodium monohydrate
CAS891191-56-3
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H351Suspected of causing cancer
Identifiers
InChIKey
WHCXDEORRDVLKS-UHFFFAOYSA-N
SMILES
COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC.[Na]
Synonyms (1)
—